Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ASSEMBLY BIOSCIENCES, INC. (ASMB) Cash Flow Statement

ASSEMBLY BIOSCIENCES, INC. (ASMB) generated -$38.5M of operating cash flow over the twelve months to 2026-06-30, spent $85000 on capital expenditure and had free cash flow of -$38.6M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ASMBASSEMBLY BIOSCIENCES, INC.Follow ASMB — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
404.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 16 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-65.0-84.1-63.0-93.422.7-51.1-41.1-38.5
Capital expenditure0.31.60.53.10.30.00.1-0.1
Free cash flow-65.3-85.6-63.4-96.522.5-51.1-41.2-38.6
Stock-based compensation28.520.621.95.25.13.14.7—

USD millions · SEC XBRL

ASSEMBLY BIOSCIENCES, INC. — questions

What is ASSEMBLY BIOSCIENCES, INC.'s operating cash flow?
-$38.5M over the twelve months to 2026-06-30.
How much does ASSEMBLY BIOSCIENCES, INC. spend on capital expenditure?
$85000 over the twelve months to 2026-06-30.
What is ASSEMBLY BIOSCIENCES, INC.'s free cash flow?
-$38.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from ASSEMBLY BIOSCIENCES, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.